Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Liver Dis. 2010 Nov;14(4):705-18. doi: 10.1016/j.cld.2010.08.003.

Hepatic progenitor cells: an update.

Author information

  • 1Liver Research Unit, Department of Morphology and Molecular Pathology, University of Leuven, Minderbroederstraat 12, Leuven, Belgium. tania.roskams@uz.kuleuven.ac.be

Abstract

Liver progenitor cells are activated in most human liver diseases. The dynamics, and therefore subpopulations, of progenitor cells are, however, different in acute versus chronic hepatocytic diseases and in biliary diseases. The role of Wnt and Notch signaling pathways in activation and differentiation of human hepatic progenitor cells holds great promise because they can be manipulated by drugs. Hepatocytic differentiation requires inhibition of Notch (numb switched on), whereas cholangiocytic differentiation requires Notch activation. In this way, the patients' own regenerative response could be supported, which could eventually even avoid the need for transplantation in several patients.

Copyright © 2010 Elsevier Inc. All rights reserved.

PMID:
21055691
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk